Table 3.

Parameters of Plasma and Urine Galectin‐3 After Correction for Potential Confounders

Variables	HF Patients (n=26)	Control Subjects (n=15)	P Value
Age, y (mean, SD)	58±4	57±4	0.462
Gender male, n (%)	26 (100)	15 (100)	N/A
Diabetes, n (%)	0 (0)	0 (0)	N/A
Smoking, n (%)	0 (0)	0 (0)	N/A
Plasma galectin‐3, ng/mL	15.1 (13.6 to 18.0)	9.7 (8.7 to 12.1)	<0.001
Urinary galectin‐3, ng/mL	28.0 (21.5 to 44.6)	39.7 (22.5 to 52.3)	0.376
Urinary galectin‐3, μg/g Cr	34.4 (25.9 to 53.9)	53.3 (23.6 to 81.6)	0.347
Urinary galectin‐3, μg/24 h	53.0 (31.7 to 90.5)	65.6 (37.4 to 115.9)	0.392
Theoretical filtered load, μg/24 h	1609 (1325 to 1915)	1164 (750 to 1529)	0.001
Galectin‐3 clearance, mL/min	2.4 (1.4 to 3.9)	2.8 (2.0 to 5.7)	0.142
Fractional galectin‐3 excretion, %	2.2 (1.6 to 3.2)	2.6 (1.0 to 4.8)	0.900

Median values with (25th to 75th percentile). Cr indicates urinary creatinine; HF, heart failure; N/A, not applicable.